CNBC Investing Club

We're trimming our AbbVie position after the stock's big jump this month

A sign stands outside a Abbvie facility in Cambridge, Massachusetts, May 20, 2021.
Brian Snyder | Reuters

(This article was sent first to members of the CNBC Investing Club with Jim Cramer. To get the real-time updates in your inbox, subscribe here.)

After you receive this email, we will be selling 100 shares of AbbVie (ABBV) at roughly $135.78. Following the trade, the Charitable Trust will own 1,000 shares of AbbVie. This trim will decrease ABBV's weighting in the portfolio from about 3.53% to about 3.22%.

More In CNBC Investing Club Newsletter

CNBC Investing ClubNew analyst reports support our view of Constellation as a great defensive play
CNBC Investing ClubWall Street notes on Apple, Qualcomm highlight the long-term opportunities in those stocks
CNBC Investing ClubTuesday's market bounce allows us to raise some cash to buy in the next downturn